Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Blood (2018) 132 (22): 2362–2374.

https://doi.org/10.1182/blood-2018-07-863431

Published: 2018

Includes: Supplemental data

Journal Articles

Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis

Francesca Gorini, Laura Azzimonti, Gloria Delfanti, Lydia Scarfò, Cristina Scielzo, Maria Teresa Bertilaccio, Pamela Ranghetti, Alessandro Gulino, Claudio Doglioni, Arianna Di Napoli, Miriam Capri, Claudio Franceschi, Federico Caligaris-Cappio, Paolo Ghia, Matteo Bellone, Paolo Dellabona, Giulia Casorati, Claudia de Lalla

Blood (2017) 129 (26): 3440–3451.

https://doi.org/10.1182/blood-2016-11-751065

Published: 2017

Includes: Supplemental data

Journal Articles

HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment

Roberta Valsecchi, Nadia Coltella, Daniela Belloni, Manfredi Ponente, Elisa ten Hacken, Cristina Scielzo, Lydia Scarfò, Maria Teresa Sabrina Bertilaccio, Paola Brambilla, Elisa Lenti, Filippo Martinelli Boneschi, Andrea Brendolan, Elisabetta Ferrero, Marina Ferrarini, Paolo Ghia, Giovanni Tonon, Maurilio Ponzoni, Federico Caligaris-Cappio, Rosa Bernardi

Blood (2016) 127 (16): 1987–1997.

https://doi.org/10.1182/blood-2015-07-657056

Published: 2016

Includes: Supplemental data

Journal Articles

IgM and IgD Receptors Differentially Contribute to CLL Survival and Chemokine Secretion: Implications for CLL Biology and Treatment

Elisa ten Hacken, PhD, Mariela Sivina, PhD, Li Ping, PhD, Susan O'Brien, MD, William G. Wierda, MD PhD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Michael J. Keating, MD, Cristina Scielzo, Paolo Ghia, MD PhD, Federico Caligaris-Cappio, MD, Jan A. Burger, MD PhD

Blood (2015) 126 (23): 2915.

https://doi.org/10.1182/blood.V126.23.2915.2915

Published: 2015

Journal Articles

Synthetic High-Density Lipoprotein-like Nanoparticles (HDL NP) Cause Apoptosis and Enhance Killing By B-Cell Receptor and BCL-2 Inhibitors in Chronic Lymphocytic Leukemia (CLL)

Kaylin Marie McMahon, Cristina Scielzo, Lydia Scarfo, Pamela Ranghetti, Shuo Yang, Leo I. Gordon, MD, Frank Giles, MDMB, Colby Shad Thaxton, MD PhD, Paolo Ghia, MD PhD

Blood (2015) 126 (23): 2949.

https://doi.org/10.1182/blood.V126.23.2949.2949

Published: 2015

Journal Articles

Anergy in CLL: Moving Towards the Clinic

Benedetta Apollonio, Tania Veliz Rodriguez, Cristina Scielzo, PhD, Maria Teresa Sabrina Bertilaccio, Lydia Scarfò, Federico Caligaris-Cappio, MD, Paolo Ghia, MD PhD

Blood (2014) 124 (21): 4677.

https://doi.org/10.1182/blood.V124.21.4677.4677

Published: 2014

Journal Articles

Nurse-like Cells Engage Sigm and Sigd on Chronic Lymphocytic Leukemia (CLL) Cells: Implications for BCR Signaling Activation and Functional Outcome

Elisa ten Hacken, PhD, Cristina Scielzo, PhD, Susan O'Brien, MD, William G. Wierda, MD PhD, Michael Keating, MBBS, Paolo Ghia, MD PhD, Federico Caligaris-Cappio, MD, Jan A. Burger, MD PhD

Blood (2014) 124 (21): 3312.

https://doi.org/10.1182/blood.V124.21.3312.3312

Published: 2014

Journal Articles

Ibrutinib Differentially Interferes With Surface IgM and IgD BCR Signaling Kinetics In Chronic Lymphocytic Leukemia

Elisa ten Hacken, Cristina Scielzo, William G. Wierda, MD, PhD, Michael J. Keating, MD, Susan O'Brien, MD, Paolo Ghia, MD, PhD, Federico Caligaris-Cappio, MD, Jan A. Burger, MD, PhD

Blood (2013) 122 (21): 4143.

https://doi.org/10.1182/blood.V122.21.4143.4143

Published: 2013

Journal Articles

Targeting B-cell anergy in chronic lymphocytic leukemia

Benedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Elisa ten Hacken, Lydia Scarfò, Pamela Ranghetti, Freda Stevenson, Graham Packham, Paolo Ghia, Marta Muzio, Federico Caligaris-Cappio

Blood (2013) 121 (19): 3879–3888.

https://doi.org/10.1182/blood-2012-12-474718

Published: 2013

Includes: Supplemental data

Journal Articles

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia

Elisa ten Hacken, Cristina Scielzo, Maria T. S. Bertilaccio, Lydia Scarfò, Benedetta Apollonio, Federica Barbaglio, Kostas Stamatopoulos, Maurilio Ponzoni, Paolo Ghia, Federico Caligaris-Cappio

Blood (2013) 121 (12): 2264–2273.

https://doi.org/10.1182/blood-2012-09-457119

Published: 2013

Includes: Supplemental data

Journal Articles

Targeting the LYN/HS1 Signaling Axis in Chronic Lymphocytic Leukemia

Elisa ten Hacken, Cristina Scielzo, Maria Teresa Sabrina Betilaccio, Lydia Scarfò, MD, Benedetta Apollonio, Maurilio Ponzoni, Kostas Stamatopoulos, Paolo Ghia, Federico Caligaris-Cappio, MD

Blood (2012) 120 (21): 928.

https://doi.org/10.1182/blood.V120.21.928.928

Published: 2012

Journal Articles

Targeting B Cell Anergy in Chronic Lymphocytic Leukemia

Benedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Elisa ten Hacken, Lydia Scarfò, Paolo Ghia, Marta Muzio, Federico Caligaris-Cappio, MD

Blood (2012) 120 (21): 3863.

https://doi.org/10.1182/blood.V120.21.3863.3863

Published: 2012

Journal Articles

General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL

Claudia Fazi, Lydia Scarfò, Lorenza Pecciarini, Francesca Cottini, Antonis Dagklis, Agnieszka Janus, Anna Talarico, Cristina Scielzo, Cinzia Sala, Daniela Toniolo, Federico Caligaris-Cappio, Paolo Ghia

Blood (2011) 118 (25): 6618–6625.

https://doi.org/10.1182/blood-2011-05-357251

Published: 2011

Journal Articles

CLL-Like MBL In the General Population Persist Over Time, without Clinical Progression, Though Carrying the Same Cytogenetic Abnormalities of CLL

Paolo Ghia, MD, PhD, Claudia Fazi, PhD, Lorenza Pecciarini, PhD, Lydia Scarfò, MD, Francesca Cottini, MD, Antonis Dagklis, PhD, Agnieszka Janus, MD, Cristina Scielzo, Cinzia Sala, PhD, Daniela Toniolo, PhD, Federico Caligaris-Cappio, MD

Blood (2010) 116 (21): 2440.

https://doi.org/10.1182/blood.V116.21.2440.2440

Published: 2010

Journal Articles

HS1 has a central role in the trafficking and homing of leukemic B cells

Cristina Scielzo, Maria T. S. Bertilaccio, Giorgia Simonetti, Antonis Dagklis, Elisa ten Hacken, Claudia Fazi, Marta Muzio, Valeria Caiolfa, Daisuke Kitamura, Umberto Restuccia, Angela Bachi, Martina Rocchi, Maurilio Ponzoni, Paolo Ghia, Federico Caligaris-Cappio

Blood (2010) 116 (18): 3537–3546.

https://doi.org/10.1182/blood-2009-12-258814

Published: 2010

Includes: Multimedia, Supplemental data

Journal Articles

MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27

Michela Frenquelli, Marta Muzio, Cristina Scielzo, Claudia Fazi, Lydia Scarfò, Claudia Rossi, Giuliana Ferrari, Paolo Ghia, Federico Caligaris-Cappio

Blood (2010) 115 (19): 3949–3959.

https://doi.org/10.1182/blood-2009-11-254656

Published: 2010

Includes: Supplemental data

Journal Articles

A novel Rag2 −/− γ c −/− -xenograft model of human CLL

Maria Teresa Sabrina Bertilaccio, Cristina Scielzo, Giorgia Simonetti, Maurilio Ponzoni, Benedetta Apollonio, Claudia Fazi, Lydia Scarfò, Martina Rocchi, Marta Muzio, Federico Caligaris-Cappio, Paolo Ghia

Blood (2010) 115 (8): 1605–1609.

https://doi.org/10.1182/blood-2009-05-223586

Published: 2010

Journal Articles

Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells.

Paolo Ghia, MD, PhD, Maria TS Bertilaccio, PhD, Cristina Scielzo, Giorgia Simonetti, Benedetta Apollonio, Claudia Fazi, Marta Muzio, PhD, Maurilio Ponzoni, MD, Federico Caligaris-Cappio, M.D.

Blood (2009) 114 (22): 360.

https://doi.org/10.1182/blood.V114.22.360.360

Published: 2009

Journal Articles

The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)–like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring

Antonis Dagklis, Claudia Fazi, Cinzia Sala, Valeria Cantarelli, Cristina Scielzo, Roberto Massacane, Daniela Toniolo, Federico Caligaris-Cappio, Kostas Stamatopoulos, Paolo Ghia

Blood (2009) 114 (1): 26–32.

https://doi.org/10.1182/blood-2008-09-176933

Published: 2009

Journal Articles

The Immunoglobulin Gene Repertoire of Low-Count CLL-Like MBL Is Different from CLL: Diagnostic Considerations and Implications for Clinical Monitoring

Antonis Dagklis, Claudia Fazi, Cinzia Sala, Valeria Cantarelli, Cristina Scielzo, Roberto Massacane, MD, Daniela Toniolo, Federico Caligaris-Cappio, MD, Kostas Stamatopoulos, MD, Paolo Ghia, MD, PhD

Blood (2008) 112 (11): 779.

https://doi.org/10.1182/blood.V112.11.779.779

Published: 2008

NARROW

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis

HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment

IgM and IgD Receptors Differentially Contribute to CLL Survival and Chemokine Secretion: Implications for CLL Biology and Treatment

Synthetic High-Density Lipoprotein-like Nanoparticles (HDL NP) Cause Apoptosis and Enhance Killing By B-Cell Receptor and BCL-2 Inhibitors in Chronic Lymphocytic Leukemia (CLL)

Anergy in CLL: Moving Towards the Clinic

Nurse-like Cells Engage Sigm and Sigd on Chronic Lymphocytic Leukemia (CLL) Cells: Implications for BCR Signaling Activation and Functional Outcome

Ibrutinib Differentially Interferes With Surface IgM and IgD BCR Signaling Kinetics In Chronic Lymphocytic Leukemia

Targeting B-cell anergy in chronic lymphocytic leukemia

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia

Targeting the LYN/HS1 Signaling Axis in Chronic Lymphocytic Leukemia

Targeting B Cell Anergy in Chronic Lymphocytic Leukemia

General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL

CLL-Like MBL In the General Population Persist Over Time, without Clinical Progression, Though Carrying the Same Cytogenetic Abnormalities of CLL

HS1 has a central role in the trafficking and homing of leukemic B cells

MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27

A novel Rag2 −/− γ c −/− -xenograft model of human CLL

Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells.

The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)–like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring

The Immunoglobulin Gene Repertoire of Low-Count CLL-Like MBL Is Different from CLL: Diagnostic Considerations and Implications for Clinical Monitoring

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only